Gufic BioScience

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE742B01025
  • NSEID: GUFICBIO
  • BSEID: 509079
INR
418.10
-14.4 (-3.33%)
BSENSE

Nov 20

BSE+NSE Vol: 50.98 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 338998,
    "name": "Gufic BioScience",
    "stock_name": "Gufic BioScience",
    "full_name": "Gufic BioSciences Ltd",
    "name_url": "stocks-analysis/gufic-bioscience",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "418.10",
    "chg": -14.4,
    "chgp": "-3.33%",
    "dir": -1,
    "prev_price": "432.50",
    "mcapval": "4,292.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 509079,
    "symbol": "GUFICBIO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE742B01025",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "50.98 k",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/gufic-bioscience-338998-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Gufic BioSciences Declines 11.33% Amid Mixed Technical Signals and Market Pressure",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/gufic-biosciences-declines-1133-amid-mixed-technical-signals-and-market-pressure-4270925",
        "imagepath": "",
        "date": "2026-11-22 09:01:09",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Nov:</strong> Intraday low hit amid price pressure, closing at Rs.440.95 (-6.49%)</p>\n                    <p><strong>16 Nov:</strong> Q2 FY27 results reveal strong revenue growth but valuation concerns</p>\n                    <p><strong>19 Nov:</strong> Technical momentum shifts with mixed indicator signals, stock closes at Rs.424.10 (-3.26%)</p>\n                    <p><strong>20 Nov:</strong> Bullish momentum emerges amid technical upgrades, closing at Rs.432.50 (+1.98%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.471.55</div></div>\n             ..."
      },
      {
        "title": "Gufic BioSciences Ltd Shows Bullish Momentum Amid Technical Upgrades",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/gufic-biosciences-ltd-shows-bullish-momentum-amid-technical-upgrades-4268720",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/GuficBioScience_technicaldot_4268720.png",
        "date": "2026-11-20 08:01:00",
        "description": "Gufic BioSciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This change is underpinned by improvements across key technical indicators including moving averages, Bollinger Bands, and the MACD, signalling renewed investor interest in this small-cap pharmaceutical and biotechnology player."
      },
      {
        "title": "Gufic BioSciences Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/gufic-biosciences-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4267438",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/GuficBioScience_technicaldot_4267438.png",
        "date": "2026-11-19 08:01:43",
        "description": "Gufic BioSciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a nuanced market sentiment. While the company’s Mojo Grade has improved from Sell to Hold as of 29 June 2026, recent price movements and technical indicators reveal a complex interplay of bullish and bearish signals that investors should carefully analyse."
      },
      {
        "title": "Gufic BioSciences Ltd Hits Intraday Low Amid Price Pressure on 16 Nov 2026",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/gufic-biosciences-ltd-hits-intraday-low-amid-price-pressure-on-16-nov-2026-4263364",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/GuficBioScience_priceRelatedfactors_4263364.png",
        "date": "2026-11-16 09:32:48",
        "description": "Gufic BioSciences Ltd experienced a notable intraday decline on 16 Nov 2026, touching a low of Rs 400.65, down 15.04% from previous levels, reflecting significant price pressure despite a broadly positive market environment."
      },
      {
        "title": "Gufic BioSciences Surges 9.79%: Four Key Drivers Behind This Week’s Rally",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/gufic-biosciences-surges-979-four-key-drivers-behind-this-weeks-rally-4262268",
        "imagepath": "",
        "date": "2026-11-15 09:00:06",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>09 Nov:</strong> New 52-week high at Rs.467.7 and intraday peak of Rs.475 with an 8.41% surge</p>\n                    <p><strong>11 Nov:</strong> Fresh 52-week high at Rs.492.75 and strong technical momentum confirmed</p>\n                    <p><strong>12 Nov:</strong> Price rebound to Rs.485.75 (+3.73%) after minor dip</p>\n                    <p><strong>13 Nov:</strong> Week closes at Rs.471.55 (-2.92%) amid profit-taking</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.429.50</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\"..."
      },
      {
        "title": "Gufic BioSciences Ltd Surges 8.41% to Day's High of Rs 475 — Outperforms Sector by 6.49 Percentage Points",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/gufic-biosciences-ltd-hits-intraday-high-with-strong-841-surge-4257039",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/GuficBioScience_priceRelatedfactors_4257039.png",
        "date": "2026-11-09 15:31:44",
        "description": "The Sensex edged up a modest 0.13% on 09 Nov 2026, while Gufic BioSciences Ltd surged 8.41%, hitting an intraday high of Rs 475. This 6.49 percentage-point outperformance over the Pharmaceuticals & Biotechnology sector signals a distinctly stock-specific strength rather than a broad market lift."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Gufic BioSciences Ltd to 52-Week High of Rs 467.7",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/gufic-biosciences-ltd-hits-new-52-week-high-at-rs4677-4256868",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/GuficBioScience_priceRelatedfactors_4256868.png",
        "date": "2026-11-09 10:35:38",
        "description": "Surging past its previous peaks, Gufic BioSciences Ltd touched a fresh 52-week high of Rs 467.7 on 09 Nov 2026, marking a significant milestone in its price momentum. This advance comes amid a backdrop of strong technical signals and sustained buying interest, setting the stage for a notable rally in the pharmaceuticals sector."
      },
      {
        "title": "Gufic BioSciences Ltd is Rated Hold by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/gufic-biosciences-ltd-is-rated-hold-by-marketsmojo-4256685",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/GuficBioScience_mojoScore_4256685.png",
        "date": "2026-11-09 10:10:40",
        "description": "Gufic BioSciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 June 2026. While the rating change occurred mid-year, the analysis and financial metrics presented here reflect the stock's current position as of 09 November 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Gufic BioSciences Ltd is Rated Hold by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/gufic-biosciences-ltd-is-rated-hold-by-marketsmojo-4243001",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/GuficBioScience_mojoScore_4243001.png",
        "date": "2026-10-29 10:11:30",
        "description": "Gufic BioSciences Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 October 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 85,
    "sid": "338998",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/gufic-biosciences-338998"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "20-Nov-2026",
      "details": "Written Transcript of Earnings Conference Call held on November 16 2026 at 04:30 p.m. is attached herewith",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "16-Nov-2026",
      "details": "Newspaper advertisement of Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30 2026 is attached herewith",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "16-Nov-2026",
      "details": "Intimation of Audio Recording of Earnings Conference Call held on November 16 2026 at 04:30 p.m. is attached herewith",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Gufic BioSciences Ltd has declared <strong>10%</strong> dividend, ex-date: 28 Aug 26",
          "dt": "2026-08-28",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

20-Nov-2026 | Source : BSE

Written Transcript of Earnings Conference Call held on November 16 2026 at 04:30 p.m. is attached herewith

Announcement under Regulation 30 (LODR)-Newspaper Publication

16-Nov-2026 | Source : BSE

Newspaper advertisement of Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30 2026 is attached herewith

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

16-Nov-2026 | Source : BSE

Intimation of Audio Recording of Earnings Conference Call held on November 16 2026 at 04:30 p.m. is attached herewith

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Gufic BioSciences Ltd has declared 10% dividend, ex-date: 28 Aug 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available